Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA grants rare pediatric disease designation to CLR-131 for neuroblastoma

May 3, 2018

Millennium Pharmaceuticals initiates first-in-human trial of TAK-164

May 3, 2018

First-in-human study of hepatitis B DNA vaccine JNJ-64300535

May 3, 2018

Enrollment ongoing in phase III trial of enfortumab vedotin for urothelial cancer

May 3, 2018

EMA approves Alpivab for the treatment of influenza

May 3, 2018

YW-1128, a WNT pathway inhibitor, shows promising in vivo results for metabolic disorders

May 3, 2018

Janssen to acquire Benevir Biopharm

May 3, 2018

Merck KGaA and SFJ partner on abituzumab in metastatic colorectal cancer

May 3, 2018

SignalRx discovers selective BRD4-BD1 inhibitor

May 3, 2018

Crysvita launched in U.S. for X-linked hypophosphatemia

May 3, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...